AI generated summary of Pubmed citation/abstract with PMID 38091481

https://pubmed.ncbi.nlm.nih.gov/38091481

Nanobody-modified gold nanoparticles show promise for selective in vitro targeting of specific cell types, but in vivo distribution is primarily in the liver and spleen, except with intraperitoneal injection which results in prominent and persistent signals in parathymic lymph nodes.